Lv1
20 积分 2024-08-14 加入
[Expression and clinical significance of SETD2 in maligant pleural mesothelioma]
8天前
已完结
Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)
19天前
已关闭
Contemporary Management of Acute Myeloid Leukemia
24天前
已完结
Tumour lysis syndrome
24天前
已完结
Long-term Survival in a Patient With Transformation of Waldenström’s Macroglobulinemia into DLBCL
1个月前
已完结
Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
1个月前
已完结
B-cell non-Hodgkin lymphomas
2个月前
已完结
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
2个月前
已完结
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
2个月前
已完结
Acute myeloid leukaemia
2个月前
已完结
皖公网安备34019202002308
